See the DrugPatentWatch profile for akynzeo
Akynzeo is a prescription medication used to prevent chemotherapy-induced nausea and vomiting. It is available through pharmacies with a valid prescription from a healthcare provider.
What is Akynzeo used for?
Akynzeo is a combination medication containing netupitant and palonosetron. It is prescribed to prevent both acute and delayed nausea and vomiting caused by certain chemotherapy regimens [1]. Netupitant is an NK1 receptor antagonist, and palonosetron is a 5-HT3 receptor antagonist. Together, they work by blocking specific pathways in the brain and gut that trigger nausea and vomiting [2].
How does Akynzeo work?
Akynzeo works by targeting two key receptors involved in the nausea and vomiting response. Netupitant blocks the neurokinin-1 (NK1) receptor, while palonosetron blocks the serotonin 5-HT3 receptor. These actions are important for preventing both the immediate (acute) and later-onset (delayed) symptoms of chemotherapy-induced nausea and vomiting [2].
Who makes Akynzeo?
Akynzeo is developed and marketed by Viatris [3].
What is the recommended dosage for Akynzeo?
The typical recommended dosage of Akynzeo is one capsule taken orally approximately one hour before the start of each cycle of chemotherapy [1]. It is crucial to follow the specific instructions provided by your doctor and on the medication label.
What are the potential side effects of Akynzeo?
Common side effects reported with Akynzeo include headache, fatigue, constipation, and indigestion [1]. Patients should discuss any concerns about potential side effects with their healthcare provider.
When does Akynzeo's patent expire?
Information regarding the patent expiry dates for Akynzeo can be found on specialized drug patent databases. Resources like DrugPatentWatch.com track these details, which are important for understanding when generic versions may become available [4].
Can generic versions of Akynzeo be developed?
The development of generic versions of Akynzeo is contingent upon the expiry of relevant patents and any associated regulatory exclusivity periods [4]. Once these protections expire, other manufacturers can apply to market generic equivalents.
How does Akynzeo compare to other anti-nausea medications?
Akynzeo is a combination therapy designed to provide broad protection against chemotherapy-induced nausea and vomiting. Other anti-nausea medications may include single-agent NK1 receptor antagonists, 5-HT3 receptor antagonists, or corticosteroids. The choice of medication depends on the specific chemotherapy regimen and individual patient needs [1][2].
What is the cost of Akynzeo?
The cost of Akynzeo can vary depending on factors such as insurance coverage, pharmacy, and location. Patients are advised to consult with their insurance provider and pharmacy for specific pricing information.
Sources:
1. Akynzeo prescribing information.
2. DrugPatentWatch.com
3. Viatris product information.
4. Viatris annual reports.